Feds: McKesson agrees to pay $150M in pill shipment case
WHEELING, W.Va. - Federal prosecutors say McKesson Corp. has agreed to pay $150 million to settle allegations that the drug wholesaler failed to detect and report pharmacies' suspicious orders of prescription pain pills.
The U.S. Justice Department and the U.S. attorney for West Virginia's northern district announced the settlement in a news release Tuesday.
The settlement commits San Francisco-based McKesson to a multi-year suspension of sales of controlled substances from distribution centers in Colorado, Ohio, Michigan and Florida. It also imposes new and enhanced compliance requirements on McKesson's distribution system.
In a statement Tuesday, Chairman and CEO John H. Hammergren said McKesson is "committed to tackling this multi-faceted problem in collaboration with all parties in the (prescription drug) supply chain."
In 2008, McKesson agreed to a $13.25 million civil penalty for similar violations.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Baton Rouge Police book murder suspect into jail
Doctors, parents worried about smell in school classrooms; District takes additional action
Area sheriff's deputy quits amid allegations he touched male teen's genitals
One suspect in custody, another wanted after deadly home invasion
At Governor's request, Restore La. agrees to expand program offerings